| Study Period | 2019 - 2030 |
| Base Year For Estimation | 2024 |
| Forecast Data Period | 2025 - 2030 |
| Historical Data Period | 2019 - 2023 |
| CAGR | 4.60 % |
Major Players
*Disclaimer: Major Players sorted in no particular order |
APAC General Surgical Devices 乐鱼体育官网 Analysis
The Asia-Pacific General Surgical Devices 乐鱼体育官网 is expected to register a CAGR of 4.6% during the forecast period.
COVID-19 had a significant impact on the Asia-Pacific 乐鱼体育官网 for general surgical devices in the initial phases, as the surgeries and procedures were delayed due to global lockdowns. However, with the easing of restrictions, the industry rebounded strongly. Over the previous two years, the 乐鱼体育官网 recovery has been led by increased sales of surgical devices, new product launches, and a high prevalence of injuries and accidents.
Factors such as the increasing demand for minimally invasive devices, cases of injuries and accidents, and healthcare expenditures in emerging economies are boosting the 乐鱼体育官网's growth. For instance, as per the 2021 report published by the NCRB, Government of India, traffic accidents resulted in injuries to 3,73,884 persons in 2021. Furthermore, as per the WHS Statistics Australia 2022 report, 52,316 traumatic joint/ligament and muscle/tendon injuries were recorded in Australia in 2021. The main reason for injury hospitalization in Australia was found to be an accident or fall. Hence, considering the growing cases of injuries and accidents, the 乐鱼体育官网 for general surgical devices is expected to grow significantly.
The increasing healthcare expenditures in emerging economies and the adoption of minimally invasive devices for surgery are promoting 乐鱼体育官网 growth. For instance, per the Parliament of Australia 2022 update, the total spending on healthcare in 2022-23 is estimated at USD 105.8 billion, representing 16.8% of the Australian government's total expenditure. Moreover, as per the India Union Budget 2022-2023, the government allocated INR 86,200 crores (about USD 10.6 million) to the Ministry of Health and Family Welfare, a nearly 16.5% increase in comparison to INR 73,932 crores (about USD 10.4 billion) in 2021 driven by increased allocation to centrally sponsored public health schemes to continue building sustainable healthcare infrastructure and ensure system preparedness to handle the increasing healthcare needs of the country. Such increased healthcare expenditure and funding are expected to boost 乐鱼体育官网 growth over the forecast period.
For instance, the growing burden of chronic diseases, along with the rising geriatric population, is likely to lead to increased demand for general surgical devices. Spending on healthcare in Asian countries is also expected to increase during the forecast period. For instance, according to the e-Stat, in Japan, households spent an average of around JPY 15,162 (USD 102.03) on medical treatments in 2022. Thus, the growing burden of diseases is expected to increase the demand for general surgical devices during the forecast period.
Hence, as per the factors mentioned above, the 乐鱼体育官网 studied is likely to witness growth over the forecast period. However, stringent government regulations and improper reimbursement for surgical devices restrain the 乐鱼体育官网 growth.
APAC General Surgical Devices 乐鱼体育官网 Trends
Handheld Devices is Expected to Witness Growth Over the Forecast Period
In Asia-Pacific countries, the rising number of surgeries is leading to the increased usage of hand-held surgical devices. The development of advanced devices, like robotic hand-held surgical devices for laparoscopic interventions, enhances a surgeon's dexterity. Needle holders are very similar in shape to hemostats, featuring jaws and handles. Needle holders allow the needle to be locked into place for suturing in various tissue types.
The 乐鱼体育官网 is growing due to the rise in minimally invasive surgical procedures, increasing product launches, and an increase in outpatient surgeries. For instance, in November 2022, Venkateshwar hospital in India, with the support of Medtronic Private Limited, performed a urological procedure using the "Hugo" robotic-assisted surgery (RAS) system in North India. Additionally, in February 2022, Smith+Nephew launched its next-generation handheld robotics platform, the CORI Surgical System, in Japan. Smith+Nephew's CORI Surgical System expands on the increasing adoption and long-term success of its NAVIO Surgical System in Japan.
The presence of competitors, mergers, acquisitions, and product launches promote 乐鱼体育官网 growth as these improve the chances of product availability and competition. For instance, in September 2022, researchers from the Indian Institute of Technology developed a simple and portable device to detect an ischemic stroke. This low-cost diagnostic technique is anticipated to help in precisely detecting ischemic stroke and can be used in rural, poor, and remote areas for early diagnosis.
Therefore, the handheld devices segment is expected to witness significant growth over the forecast period due to the abovementioned factors.
Understand The Key Trends Shaping This 乐鱼体育官网
Download PDF
India is Expected to Dominate the General Surgical Devices 乐鱼体育官网
India is expected to witness growth in the 乐鱼体育官网 studied owing to factors such as increasing cases of accidents and injuries, a rise in healthcare expenditure, and government funding for health and welfare. As per the 2021 report from NCRB, the major traffic accidents in India comprised 4,03,116 road accidents, 17,993 railway accidents, and 1,550 railway crossing accidents in 2021. Since accident cases in India are considerably high, which can cause severe injury and lead to hospitalization and surgery, the 乐鱼体育官网 for surgical devices is anticipated to witness growth.
The Indian government invests and funds more in health and welfare, which boosts the 乐鱼体育官网 for surgical devices, allowing hospitals and healthcare systems to afford and purchase more surgical devices. For instance, as per the India Union Budget 2022-2023, to strengthen blood transfusion services, a new allocation of INR 404 crores (about USD 49 million) was announced to develop hospital-based or stand-alone blood centers. As per the same source, allocated INR 5,156 crores (about USD 625.6 thousand) outlay as part of the PM Ayushman Bharat Health Infrastructure Mission (PM-ABHIM) announced in October 2021 to strengthen health infrastructure at mission mode approach and improve primary, secondary, and tertiary care services.
The presence of competitors and product launches are the major drivers of 乐鱼体育官网 growth. For instance, in April 2021, Dolphin Sutures Company launched non-absorbable polytetrafluoroethylene sutures, TEFLENE. It is a monofilament, non-absorbable, extremely smooth suture material composed of a strand of polytetrafluoroethylene (PTFE). The company also expanded its product portfolio in India. Furthermore, in February 2022, Bengaluru-based Futura Surgicare Pvt Ltd launched Hemostatic products under the brand Hemostax (Oxidised Regenerated Cellulose) under a new vertical, Dolphin Hemostats. Hemostax Standard is an absorbable hemostat that is designed to help surgeons control bleeding more efficiently. Such increased product launches in India promote 乐鱼体育官网 growth over the forecast period.
Therefore, owing to the aforesaid factors, the growth of the studied 乐鱼体育官网 is anticipated in India.
Get Analysis on Important Geographic 乐鱼体育官网s
Download PDF
APAC General Surgical Devices Industry Overview
The Asia-Pacific 乐鱼体育官网 for general surgical devices is fragmented because of the presence of many large, medium, and small players. The competitive landscape includes an analysis of a few international as well as local companies which hold the 乐鱼体育官网 shares and are well known include B. Braun Melsungen AG, Boston Scientific Corporation, Conmed Corporation, Medtronic PLC, and Johnson & Johnson, among others.
APAC General Surgical Devices 乐鱼体育官网 Leaders
-
Boston Scientific Corporation
-
Johnson & Johnson
-
Medtronic PLC
-
B. Braun Melsungen AG
-
Conmed Corporation
- *Disclaimer: Major Players sorted in no particular order
Need More Details on 乐鱼体育官网 Players and Competitors?
Download PDF
APAC General Surgical Devices 乐鱼体育官网 News
- September 2022: Olympus Corporation, a MedTech company, launched its THUNDERBEAT Open Fine Jaw Type X surgical energy devices for open surgery. With a new thermal shield, the THUNDERBEAT Open Fine Jaw Type X surgical energy device is designed to support safer procedures. The device is available commercially in Japan.
- September 2022: Japanese firm Olympus Corporation launched VISERA ELITE III, its newest surgical visualization platform that addresses the needs of healthcare professionals (HCPs) for endoscopic procedures across multiple medical disciplines.
APAC General Surgical Devices Industry Segmentation
As per the scope, surgical devices serve a specific purpose during surgery. Surgical devices have generic use, while some specific tools are designed for particular procedures or surgeries. The Asia-Pacific 乐鱼体育官网 for general surgical devices is segmented by Product (Handheld Devices, Laparoscopic Devices, Electrosurgical Devices, Wound Closure Devices, Trocars and Access Devices, and Other Products), Application (Gynecology and Urology, Cardiology, Orthopedic, Neurology, and Other Applications), and Geography (China, Japan, India, Australia, South Korea, and the rest of Asia-pacific). The report offers the value (in USD million) for the above segments.
| By Product | Handheld Devices |
| Laparoscopic Devices | |
| Electro Surgical Devices | |
| Wound Closure Devices | |
| Trocars and Access Devices | |
| Other Products | |
| By Application | Gynecology and Urology |
| Cardiology | |
| Orthopedic | |
| Neurology | |
| Other Applications | |
| Geography | China |
| Japan | |
| India | |
| Australia | |
| South Korea | |
| Rest of Asia-Pacific |
Need A Different Region or Segment?
Customize Now
APAC General Surgical Devices 乐鱼体育官网 Research FAQs
What is the current Asia-Pacific General Surgical Devices 乐鱼体育官网 size?
The Asia-Pacific General Surgical Devices 乐鱼体育官网 is projected to register a CAGR of 4.6% during the forecast period (2025-2030)
Who are the key players in Asia-Pacific General Surgical Devices 乐鱼体育官网?
Boston Scientific Corporation, Johnson & Johnson, Medtronic PLC, B. Braun Melsungen AG and Conmed Corporation are the major companies operating in the Asia-Pacific General Surgical Devices 乐鱼体育官网.
What years does this Asia-Pacific General Surgical Devices 乐鱼体育官网 cover?
The report covers the Asia-Pacific General Surgical Devices 乐鱼体育官网 historical 乐鱼体育官网 size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Asia-Pacific General Surgical Devices 乐鱼体育官网 size for years: 2025, 2026, 2027, 2028, 2029 and 2030.
Our Best Selling Reports
Asia-Pacific General Surgical Devices Industry Report
Statistics for the 2025 Asia-Pacific General Surgical Devices 乐鱼体育官网 share, size and revenue growth rate, created by Mordor Intelligence鈩� Industry Reports. Asia-Pacific General Surgical Devices analysis includes a 乐鱼体育官网 forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.
